Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on August 6, 2026

Aug. 6, 2026

RenovoRx Announces First Commercial Clinical Use of RenovoCath® in Sarcoma Patient Treatment, Marking Expansion of Targeted Drug-Delivery Device to Other Solid Tumors

Indeterminate GlobeNewswire

Aug. 6, 2026

Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series

Indeterminate GlobeNewswire

Aug. 6, 2026

ALX Oncology Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Barinthus Bio Reports Second Quarter 2026 Financial Results and Updates on Corporate Developments

Indeterminate GlobeNewswire

Aug. 6, 2026

MIRA Reports Positive 7-Day Dog Study Results for SKNY-1

Indeterminate GlobeNewswire

Aug. 6, 2026

Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Vortex Energy Receives Final Technical Study Results for the Robinsons River Salt Project

Indeterminate GlobeNewswire

Aug. 6, 2026

GoldHaven Awards Contract for Eight-Hole, 1,650-Metre Phase II Drill Program at Copeçal West Target, Brazil

Indeterminate GlobeNewswire

Aug. 6, 2026

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Indeterminate GlobeNewswire

Aug. 6, 2026

Clearmind Reaches Key Clinical Trial Milestone as DSMB Unanimously Clears Progression in AUD Study

Indeterminate GlobeNewswire

Aug. 6, 2026

Domestic Metals to Commence Drill Program at Smart Creek Project, Montana

Indeterminate GlobeNewswire

Aug. 6, 2026

InflaRx Reports Second Quarter 2026 Results and Highlights Key Achievements and Expected Milestones

Indeterminate GlobeNewswire

Aug. 6, 2026

HPQ ENDURA+ GEN4 21700 Cells Achieve UN 38.3 Certification Supports Ongoing Customer Qualification Activities

Indeterminate GlobeNewswire

Aug. 6, 2026

Les cellules HPQ ENDURA+ GEN4 21700 obtiennent la certification UN 38.3; les activités de qualification auprès des clients progressent

Indeterminate GlobeNewswire

Aug. 6, 2026

Foghorn Therapeutics Provides Second Quarter 2026 Financial and Corporate Update

Indeterminate GlobeNewswire

Aug. 6, 2026

Verano Announces Upcoming Conference Participation

Indeterminate GlobeNewswire

Aug. 6, 2026

Ligand Reports Second Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Aug. 6, 2026

Aya Gold & Silver Acquires Strategic Exploration Portfolio in Morocco

Indeterminate GlobeNewswire

Aug. 6, 2026

Assessment of AAE-C1INH Disease Burden and Validation of Clinical Trial Endpoints Published in Frontiers in Immunology

Indeterminate GlobeNewswire